Source: American Journal of Cardiology. Unidade: FMRP
Subjects: INFARTO DO MIOCÁRDIO, CARDIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BROMBERG-MARIN, Guilherme et al. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in Non-ST-Segment elevation myocardial infarction (from the national registry of myocardial infarction-4). American Journal of Cardiology, v. 98, n. 9, p. 1125-1131, 2006Tradução . . Acesso em: 06 out. 2024.APA
Bromberg-Marin, G., Marin-Neto, J. A., Parsons, L. S., Canto, J. G., & Rogers, W. J. (2006). Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in Non-ST-Segment elevation myocardial infarction (from the national registry of myocardial infarction-4). American Journal of Cardiology, 98( 9), 1125-1131.NLM
Bromberg-Marin G, Marin-Neto JA, Parsons LS, Canto JG, Rogers WJ. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in Non-ST-Segment elevation myocardial infarction (from the national registry of myocardial infarction-4). American Journal of Cardiology. 2006 ; 98( 9): 1125-1131.[citado 2024 out. 06 ]Vancouver
Bromberg-Marin G, Marin-Neto JA, Parsons LS, Canto JG, Rogers WJ. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in Non-ST-Segment elevation myocardial infarction (from the national registry of myocardial infarction-4). American Journal of Cardiology. 2006 ; 98( 9): 1125-1131.[citado 2024 out. 06 ]